Investors and analysts are running out of superlatives to describe Palantir (NASDAQ:PLTR) following the company’s Q4 2024 print.Maximize Your ...
Hosted on MSN5h
ResMed Inc Director Plans Sale of 2,000 SharesAn announcement from Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( ($AU:RMD) ) is now available. ResMed Inc has ...
Symal Group Limited ( ($AU:SYL) ) just unveiled an announcement. Symal Group Limited announced it will release its half-year financial results for ...
For investors who missed the PLTR rally, there might be another option positioning itself for a sustained run.
Lake Street raised the firm’s price target on Limbach Holding (LMB) to $125 from $100 and keeps a Buy rating on the shares.
B. Riley lowered the firm’s price target on Gentex (GNTX) to $32.50 from $37 and keeps a Buy rating on the shares following the Q4 report. The firm expects both the company’s sales and gross margin ...
Despite struggles in 2024, Lucid (NASDAQ: LCID) could be a strong contender for 2025, backed by solid fundamentals and growth ...
The TipRanks All-star Analyst of the Day title goes to Analyst Mariana Perez Mora of research firm Bank of America Securities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback